Status
Conditions
Treatments
About
The project's primary purpose is to test the hypothesis that oral administration of a low single dose of β-antagonist propranolol (40 mg) reduces pain sensitivity in patients with masticatory muscle pain.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
16 participants in 2 patient groups
Loading...
Central trial contact
Karina H. Bendixen, DDS, PhD fellow
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal